Glaukos Corporation earnings per share and revenue
On Oct 29, 2025, GKOS reported earnings of -0.16 USD per share (EPS) for Q3 25, beating the estimate of -0.26 USD, resulting in a 39.14% surprise. Revenue reached 133.54 million, compared to an expected 124.99 million, with a 6.84% difference. The market reacted with a +13.89% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analysts forecast an EPS of -0.22 USD, with revenue projected to reach 136.47 million USD, implying an increase of 37.50% EPS, and increase of 2.20% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Intuitive Surgical Inc.
Report Date
Jan 22, 2026 For Q4 25
Estimate
$2.30
Actual
$2.52
Surprise
+9.86%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.63%
FAQ
What were Glaukos Corporation's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Glaukos Corporation reported EPS of -$0.16, beating estimates by 39.14%, and revenue of $133.54M, 6.84% above expectations.
How did the market react to Glaukos Corporation's Q3 2025 earnings?
The stock price moved up 13.89%, changed from $77.09 before the earnings release to $87.80 the day after.
When is Glaukos Corporation expected to report next?
The next earning report is scheduled for Feb 17, 2026.
What are the forecasts for Glaukos Corporation's next earnings report?
Based on 18
analysts, Glaukos Corporation is expected to report EPS of -$0.22 and revenue of $136.47M for Q4 2025.